Pfenex (PFNX) Misses Q2 EPS by 3c, Miss on Revenues
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mailGet Alerts PFNX Hot Sheet
Join SI Premium – FREE
Pfenex (NYSE: PFNX) reported Q2 EPS of ($0.52), $0.03 worse than the analyst estimate of ($0.49). Revenue for the quarter came in at $3 million versus the consensus estimate of $3.1 million.
For earnings history and earnings-related data on Pfenex (PFNX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nurix Therapeutics, Inc. (NRIX) Reports Q3 EPS of $4.73
- Figs shares jump after Q2 earnings review
- Truist Names Top Infrastructure Services Stocks
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
